ENLV
Enlivex Therapeutics Ltd
NASDAQ: ENLV · HEALTHCARE · BIOTECHNOLOGY
$0.82
-0.46% today
Updated 2026-05-01
Market cap
$197.61M
P/E ratio
0.03
P/S ratio
—
EPS (TTM)
$25.48
Dividend yield
—
52W range
$1 – $2
Volume
0.6M
Enlivex Therapeutics Ltd (ENLV) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+34.1%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+77.7%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-0.8%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-1.6%
2025-12-01
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-25 | $-0.05 | +64.0% | $1.15 | $1.15 | +0.0% |
| 2025-12-01 | $-0.12 | +18.7% | $0.97 | $0.95 | -1.6% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.14 | $-0.05 | +64.0% | — | — |
| 2025-09-30 | $-0.14 | $-0.12 | +18.7% | — | — |
| 2025-06-30 | $-0.15 | $-0.08 | +47.6% | — | — |
| 2025-03-31 | $-0.16 | $-0.15 | +6.3% | — | — |
| 2024-12-31 | $-0.16 | $-0.23 | -43.8% | — | — |
| 2024-09-30 | $-0.20 | $-0.16 | +17.9% | — | — |
| 2024-06-30 | $-0.15 | $-0.16 | -6.7% | — | — |
| 2024-03-31 | $-0.25 | $-0.22 | +12.0% | — | — |
| 2023-12-31 | $-0.28 | $-0.48 | -71.4% | — | — |
| 2023-09-30 | $-0.32 | $-0.32 | +0.0% | — | — |
| 2023-06-30 | $-0.46 | $-0.40 | +13.0% | — | — |
| 2023-03-31 | $-0.40 | $-0.39 | +2.5% | — | — |
Frequently asked questions
Has Enlivex Therapeutics Ltd beaten earnings estimates?
Enlivex Therapeutics Ltd has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +34.1% over the last 4 quarters.
How does ENLV stock react to earnings?
ENLV stock has moved an average of -0.8% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.